Inhaled insulin dosage control delivery enhanced by controlling

Details Inhaled insulin dosage control delivery enhanced by controlling Inhaled insulin dosage control delivery enhanced by controlling

1998-09-25

1999-08-24

Lewis, Aaron J.

Surgery

Liquid medicament atomizer or sprayer

12820022, 12820423, 12820312, A61M 1100

Patent

active

059412402

ABSTRACT:
Dosages of inhaled insulin are controlled within a narrow range by controlling the total volume of air inhaled by a patient. By repeatedly delivering aerosolized insulin with the same total inhaled volume of air, the amount of insulin delivered to the patient each time is consistent. A device for delivering insulin by inhalation is disclosed which device comprises a means for measuring inhaled volume and for halting inhalation at a pre-determined point. The device also comprises an adjustable means for applying various amounts of force to a container of formulation to expel different amounts of drug from the container based on the force applied.

REFERENCES:
patent: 3812854 (1974-05-01), Michaels et al.
patent: 3991304 (1976-11-01), Hillsman
patent: 4106503 (1978-08-01), Rosenthal et al.
patent: 4361401 (1982-11-01), Smith et al.
patent: 4604847 (1986-08-01), Moulding, Jr. et al.
patent: 4627432 (1986-12-01), Newell et al.
patent: 4677975 (1987-07-01), Edgar et al.
patent: 4686231 (1987-08-01), Bender et al.
patent: 4796614 (1989-01-01), Nowacki et al.
patent: 4819629 (1989-04-01), Jonson
patent: 4877989 (1989-10-01), Drews et al.
patent: 4907581 (1990-03-01), King
patent: 4926852 (1990-05-01), Zoltan et al.
patent: 4984158 (1991-01-01), Hillsman
patent: 5006343 (1991-04-01), Benson et al.
patent: 5011678 (1991-04-01), Wang et al.
patent: 5167506 (1991-01-01), Kilis et al.
patent: 5284133 (1994-02-01), Burns et al.
patent: 5364838 (1994-11-01), Rubsamen
patent: 5394866 (1995-03-01), Ritson et al.
patent: 5404871 (1995-04-01), Goodman et al.
patent: 5450336 (1995-09-01), Rubsamen et al.
patent: 5497944 (1996-03-01), Weston et al.
patent: 5743250 (1998-04-01), Gonda et al.
Colthrope, P., et al., 1992, "The pharmacokinetics of pulmonary delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit," Parmaceutical Research 9:764-8.
Elliott, R.B. et al., "Parenteral absorption of insulin from the lung in diabetic children," 1987, Aust. Paediatr. J. 23: 298-297.
Kohler, D., 1990, "Aerosols for systemic treatment," Lung, Suppl.:677-84.
Laube, B.L. et al., 1991, "Deposition, clearance, and effects in the lung," Journal Aeorsol Medicine 4:286.
Laube, B.L. et al., "Preliminary Study of the Efficacy of insulin aerosol delivered by oral inhalation in diabetic patients," 1994, JAMA, 269:2106-2109.
Moses, A.C. et al., 1983, "Insulin administed intranasally as an insulin-bile salt aerosos-effectiveness and reproducibility in normal and diabetic subjects," Diabetes 32:1040-7.
Newman, S.P. et al., "Deposition of pressurized aerosols in the human respiratory tract," 1981, Thorax, 36:52-55.
Newman, S.P. et al., "How Should a pressurized .beta.-adrenergic bronchodilator be inhaled?" 1981, Eur. J. Respir. Dis. 62:3-21.
Newman, S.P. et al., "Deposition of pressurized suspension aerosols inhaled through extension devices," 1981, Am. Rev. Respir. Dis. 124:317-320.
Newman, S.P. et al., Deposition and Effects of Inhalation Aerosols, Royal Free Hospital, London, (1983) ISBN-91-86058-03-07.
Remington's Pharmaceutical Sciences, A.R. Gennaro, ed., 1985, Mack Publishing Co.
Salzman, R., 1985, "Intranasal aerosolized insulin mixed-meal studies and long-term use in type 1 diabetes," New England Journal of Medicine 213:1078-84.
Sciarra et al., 1976, "In Vitro Release of Therapeutically Active Ingredients from Polymer Matrixes," Journal of Pharmaceutical Sciences 65(4): 1519-1522.
Wigley, F.M. et al., "Insulin across respiratory mucosae by aerosol delivery," 1971, Diabetes, 20:552-556.
Yoshida, H., et al., 1979, "Absorption of insulin delivered to rabbit trachea using aeroso dosage form," Journal Pharmaceutical Sciences 68:670-1.

Affiliated with

Also associated with

Rating

Inhaled insulin dosage control delivery enhanced by controlling does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhaled insulin dosage control delivery enhanced by controlling , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhaled insulin dosage control delivery enhanced by controlling will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-457907